The protective role of PARP was the basis for the development of PARP inhibitors as anti‐cancer drugs, which, especially when administered in combination with DNA‐damaging compounds or radiation, promote the death of mitotically active cells (Bhamidipati et al. 2023). The gene discussed is PARP1; the disease is cancer.